Lecture 30 - Hypersensitivity, Allergy Flashcards
Type I hypersensitivity
1)
2)
1) Immediate hypersensitivity
2) IgE, mast cell, lipid mediators
Type II hypersensitivity
1)
2)
1) Antibody-mediated hypersensitivity
2) IgM and IgG against cell-bound or ECM antigen
Type III hypersensitivity
1)
2)
1) Immune complex hypersensitivity
2) IgM and IgG form immune complexes with antigen, complex deposition
Type IV hypersensitivity
1)
2)
1) Delayed-type hypersensitivity
2) CD4+ mediated
Atopic
1) Genetic predisposition to allergies
2) Enhanced tendency to produce IgE against environmental antigens
Allergy
1)
2)
1) Type I hypersensitivity
2) Immune-mediated inflammatory response to otherwise harmless environmental antigens
Traits of an atopic individual
1)
2)
3)
1) High levels of IgE (exact level varies with condition)
2) High levels of eosinophils
3) High levels of IL-4-secreting Th2
Common features of allergens 1) 2) 3) 4) 5) 6)
1) Inhaled antigens are highly-soluble proteins carried by small particles
2) Ingested antigens are highly resistant to degradation
3) Very stable
4) High solubility in body fluids
5) Introduced in very low doses
6) Induce Th2 response
Most severe type of type I hypersensitivity
Anaphylaxis
Phases of type I hypersensitivity
1)
2)
1) Sensitisation
2) Response
Types of type I responses
1)
2)
1) Local (allergic rhinitis, bronchoconstriction, conjunctivitis)
2) Systemic (anaphylaxis, this is less common)
Example of type I sensitisation and response 1) 2) 3) 4) 5) 6) 7)
1) Enzyme Der p 1 from dust mites enters body
2) Der p 1 enzymatically degrades occludin in tight junctions between epithelial cells. Enters mucosa
3) Der p 1 is taken up by dendritic cells and presented in the nearest lymph node
4) Th2 is primed by DC presentation
5) Th2 induces B cell to differentiate to plasma cell, isotype switch to IgE (specific to der p 1)
6) Plasma cell travels to mucosa, releases IgE, which sensitise resident mast cells against der p 1 (FceR1)
7) Next time der p 1 is encountered, causes mast cell degranulation
Which cytokines do Th2 secrete in response to sensitisation to allergen?
IL-4, IL-13
Effects of mast cell stimulation in type I response
1)
2)
3)
1) Secretion of preformed mediators (histamine)
2) Synthesis and secretion of lipid inflammatory mediators (prostaglandin, leukotrienes)
3) Synthesis and secretion of cytokines (IL-3, IL-4, IL-5, IL-13)
Effects of mast cell degranulation on GIT 1) 2) 3) 4)
1) Increased mucus, fluid secretion
2) Peristalsis
3) Vomiting (more severe)
4) Diarrhoea (more severe)
Effects of mast cell degranulation on airways 1) 2) 3) 4) 5)
1) Decrease diameter
2) Increase mucus secretion
3) Wheezing
4) Coughing
5) Phlegm
Effects of mast cell degranulation on blood vessels 1) 2) 3) 4) 5) 6)
1) Systemic effects, anaphylaxis
2) Increase blood flow
3) Increase permeability
4) Increase cells and proteins in tissue
5) Increase fluid in tissue
6) Increase lymph flow, effector response
Immediate phase of type I response 1) 2) 3) 4) 5)
1) Redness (flare)
2) Soft swelling - leakage of plasma from venules (wheal)
3) IgE mediated
4) Caused by release of preformed mediators (histamine)
5) Minutes after exposure to intradermal antigen
Late phase of type I response 1) 2) 3) 4) 5)
1) Hard swelling
2) Accumulation of neutrophils, Th2, eosinophils
3) Involves oedema, smooth muscle contraction
4) Caused by induced mediators (chemokines, cytokines, leukotrienes)
5) Hours to days after exposure to intradermal antigen
Immediate phase wheal and flare
1)
2)
3)
1) Wheal - localised swelling around site of challenge
2) Flare - Blood vessels around wheal dilate, become more permeable
3) Due to preformed mediators (histamine)
Outcomes of type II response
1)
2)
1) Injury due to activation of effector mechanisms
2) Abnormal physiological response to antibody binding to antigen
How can antibody binding to an allergen cause injury?
1)
2)
3)
1) C’ activation
2) Recruitment of inflammatory cells
3) Activation via Fc receptor
Examples of diseases caused by abnormal physiological response in type II hypersensitivity
1)
2)
1) Grave’s disease
2) Myasthenia gravis
Which type of hypersensitivity leads to haemolytic disease of a newborn?
Type II (due to preformed maternal IgG antibodies against newborn Rh+ blood cells)